These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36428509)

  • 1. Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis.
    Zhuang Y; Wang J; Li H; Chen Y; Chen C; Wang DW
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis.
    Wang J; He M; Li H; Chen Y; Nie X; Cai Y; Xie R; Li L; Chen P; Sun Y; Li C; Yu T; Zuo H; Cui G; Miao K; Zhao C; Jiang J; Heidecker B; Barnett O; Maisel A; Chen C; Wang DW
    J Am Heart Assoc; 2022 Apr; 11(7):e024417. PubMed ID: 35377184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miR-4763-3p Is a Novel Potential Biomarker Candidate for Human Adult Fulminant Myocarditis.
    Nie X; He M; Wang J; Chen P; Wang F; Lai J; Li C; Yu T; Zuo H; Cui G; Miao K; Jiang J; Wang DW; Chen C
    Mol Ther Methods Clin Dev; 2020 Jun; 17():1079-1087. PubMed ID: 32478123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and Significance of Circulating microRNA-29b in Adult Fulminant Myocarditis].
    Chen JH; He J; Zhou R; Zheng N
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Feb; 44(1):102-109. PubMed ID: 35300771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoglobin and left ventricular ejection fraction as predictive markers for death in children with fulminant myocarditis.
    Xie T; Zang X; Xiong Y; Yang C; Li F; Wang D; Shu Y; Mo X; Chen M
    Front Pediatr; 2022; 10():949628. PubMed ID: 36186650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Hypothesis: Disproportion Between Cardiac Troponin and B-Type Natriuretic Peptide Levels-A High Risk and Poor Prognostic Biomarker in Patients With Fulminant Myocarditis?
    Yu SR; Zhang CY; Xiong WJ; Chen JT; Song JX; Chen H
    Heart Lung Circ; 2021 Jun; 30(6):837-842. PubMed ID: 33582021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum exosome microRNA panel as a noninvasive biomarker for molecular diagnosis of fulminant myocarditis.
    Zhang Y; Li X; Wang D; Jiang X; Zhang M; Lv K
    Mol Ther Methods Clin Dev; 2021 Mar; 20():142-151. PubMed ID: 33473354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absolute and relative changes in high-sensitivity cardiac troponin I are associated with the in-hospital mortality of patients with fulminant myocarditis.
    Liu C; Wang Z; Chen K; Cui G; Chen C; Wang L; Jiang J
    BMC Cardiovasc Disord; 2021 Nov; 21(1):571. PubMed ID: 34847863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.
    Li JY; Yang XY; Wang XF; Jia X; Wang ZJ; Deng AP; Bai XL; Zhu L; Li BH; Feng ZB; Li Y; Wang L; Jin S
    Sci Rep; 2017 Sep; 7(1):11272. PubMed ID: 28900239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study: cardiac MRI of fulminant myocarditis in children-can we evaluate the short-term outcomes?
    Wang H; Zhao B; Jia H; Gao F; Zhao J; Wang C
    PeerJ; 2016; 4():e2750. PubMed ID: 27994968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis.
    Wang Z; Wang Y; Lin H; Wang S; Cai X; Gao D
    Medicine (Baltimore); 2019 Feb; 98(8):e14697. PubMed ID: 30813218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiles and functional analysis of plasma tRNA-derived small RNAs in children with fulminant myocarditis.
    Wang J; Han B; Yi Y; Wang Y; Zhang L; Jia H; Lv J; Yang X; Jiang D; Zhang J
    Epigenomics; 2021 Jul; 13(13):1057-1075. PubMed ID: 34114472
    [No Abstract]   [Full Text] [Related]  

  • 13. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.
    Lee J; Lee J; Baek S; Koh JH; Kim JW; Kim SY; Chung SH; Choi SS; Cho ML; Kwok SK; Ju JH; Park SH
    J Autoimmun; 2019 Jun; 100():114-119. PubMed ID: 30922727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Characterization by Mapping and Strain Cardiac MRI to Evaluate Myocardial Inflammation in Fulminant Myocarditis.
    Li H; Zhu H; Yang Z; Tang D; Huang L; Xia L
    J Magn Reson Imaging; 2020 Sep; 52(3):930-938. PubMed ID: 32080960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long term prognosis of fulminant myocarditis and predictors related to impaired cardiac function post discharge].
    Jiang JG; Liu C; Cui GL; Chen C; Zuo HJ; Li R; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):263-269. PubMed ID: 35340145
    [No Abstract]   [Full Text] [Related]  

  • 16. Fulminant myocarditis: Characteristics, treatment, and outcomes.
    Veronese G; Ammirati E; Cipriani M; Frigerio M
    Anatol J Cardiol; 2018 Apr; 19(4):279-286. PubMed ID: 29537977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal echocardiography findings in patients with fulminant myocarditis: beyond ejection fraction decline.
    Zuo H; Li R; Ma F; Jiang J; Miao K; Li H; Nagel E; Tadic M; Wang H; Wang DW
    Front Med; 2020 Jun; 14(3):284-292. PubMed ID: 31858367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis.
    Ammirati E; Cipriani M; Lilliu M; Sormani P; Varrenti M; Raineri C; Petrella D; Garascia A; Pedrotti P; Roghi A; Bonacina E; Moreo A; Bottiroli M; Gagliardone MP; Mondino M; Ghio S; Totaro R; Turazza FM; Russo CF; Oliva F; Camici PG; Frigerio M
    Circulation; 2017 Aug; 136(6):529-545. PubMed ID: 28576783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction.
    Ammirati E; Veronese G; Brambatti M; Merlo M; Cipriani M; Potena L; Sormani P; Aoki T; Sugimura K; Sawamura A; Okumura T; Pinney S; Hong K; Shah P; Braun Ö; Van de Heyning CM; Montero S; Petrella D; Huang F; Schmidt M; Raineri C; Lala A; Varrenti M; Foà A; Leone O; Gentile P; Artico J; Agostini V; Patel R; Garascia A; Van Craenenbroeck EM; Hirose K; Isotani A; Murohara T; Arita Y; Sionis A; Fabris E; Hashem S; Garcia-Hernando V; Oliva F; Greenberg B; Shimokawa H; Sinagra G; Adler ED; Frigerio M; Camici PG
    J Am Coll Cardiol; 2019 Jul; 74(3):299-311. PubMed ID: 31319912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15
    Xie J; Christiaens I; Yang B; Trus I; Devriendt B; Cui T; Wei R; Nauwynck HJ
    Vet Res; 2018 Jul; 49(1):67. PubMed ID: 30021620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.